NIH-funded research R15 grant

Improving how antibodies attach to gold nanoparticles for better diagnostics

Official title: Enzyme-Mediated Site-Specific Conjugation of Antibodies to Nanoparticles

Funded at Illinois State University · NIH-10436681 · Data updated 2026-11-12

This study is working on a new way to attach antibodies to tiny gold particles to make medical tests more reliable and effective, which could help doctors detect different health conditions more accurately.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionIllinois State University
NIH-funded
Lab location1 site (Normal, United States)
Project startSeptember 1, 2022
Project endAugust 31, 2025
Funding year2022
Award (this year)$369,921
NIH project number1R15GM146167-01
Project IDNIH-10436681 on NIH RePORTER

Who could benefit from this research

Could help

Patients who may benefit from this research include those requiring advanced diagnostic testing for various medical conditions.

Less likely to help

Patients who are not undergoing diagnostic testing or do not require antibody-based diagnostics may not benefit from this research.

What this research studies

This research focuses on enhancing the way antibodies are connected to gold nanoparticles, which are tiny particles that can be used in medical diagnostics. The team aims to develop a method that allows for a more stable and effective attachment of antibodies to these nanoparticles, ensuring that they maintain their activity and orientation. By using enzyme-mediated techniques, the researchers hope to create highly active and stable antibody-gold nanoparticle conjugates that can improve diagnostic tests. This work could lead to better detection methods for various medical conditions.

Why it matters

Potential benefit: If successful, this research could lead to more accurate and reliable diagnostic tests for patients.

How similar studies have gone: Previous research has shown promise in improving antibody conjugation techniques, suggesting that this approach could lead to significant advancements in diagnostic methods.

Where this research is happening

  • Illinois State University
    Normal, United States
    Active

Researchers

  • Principal investigator: Driskell, Jeremy D. — Illinois State University
  • Study coordinator: Driskell, Jeremy D.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.